S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94

OnTrak (NASDAQ: OTRK) Narrative, Stock Hitting on All Cylinders Towards These Levels

Wednesday, August 12, 2020 | Jea Yu
OnTrak (NASDAQ: OTRK) Narrative, Stock Hitting on All Cylinders Towards These LevelsVirtual behavioral and addiction treatment platform Ontrak, Inc. (NASDAQ: OTRK) shares have been on a tear to new all-time highs. While the recovery of the benchmark S&P 500 index (NYSEARCA: SPY) has been impressive, shares of ONTK have more than doubled since pre-COVID 19 levels. Formerly known as Catasys (NASDAQ: CATS) , this virtual addiction treatment play was profiled when it was trading down to the $17s in March 2020 as the COVID-19 pandemic was triggering stay-in-shelter mandates worldwide. This breathed new life into remote tele-healthcare stocks like Teladoc (NASDAQ: TDOC) and Livongo Health (NASDAQ: LVGO), who recently announced an $18.5 billion merger. This deal further adds to the speculation that Ontrak could be an acquisition target. Investors may want to track the price trajectories for this white-hot stock to better plan potential entry and exits levels.

Q2 2020 Earnings Release

On August 5, 2020, Ontrak released its second-quarter fiscal 2020 results for the quarter ending June 2020. The Company reported a loss of (-$0.24) per share versus consensus analyst estimates of a loss of (-$0.33) per share, beating estimates by $0.07 per share. Revenues rose 124% year-over-year (YoY) to $17.2 million versus $17.1 million consensus estimates. The Company enrolled 3,389 new members for the quarter. Ontrak reaffirms 2020 revenues of “at least” $90 million, a 156% YoY revenue spike. The stock peaked near the $63.93 Fibonacci (fib) level indicating a 50% gap as a reaction to the earnings.

COVID-19 Effects on Mental Health

The effects of COVID-19 on mental health has taken a dramatic toll as the Company pointed out a crisis mental health hotline seeing an 891% spike in calls. Investors are awakening to the mental health consequences that arise from social distancing and extended periods of isolation in the backdrop of a global pandemic. Mental health issues can lead to physical maladies, which can drive healthcare costs higher. Ontrak specifically addresses these mental health issues through its network of providers on its data-driven platform to ensure a reductions in healthcare costs as the essence of its operating model.

Pandemic Driven Perfect Storm Narrative

The 50% earnings gap was driven by a perfect storm of narratives including telemedicine that accommodates the behavioral health angle especially prevalent from the effects of isolation mandates, data-driven treatment platform with sticky network effects and a tiny 17 million share float. The evidenced-based telemedicine treatment platform for behavioral and mental health thrives on cost savings and optimization. Ontrak makes money by saving money for payors including top health insurance carriers Humana (NYSE: HUM) , United Healthcare (NYSE: UNH) and various Blue Cross Blue Shield plans. A big win was announced on June 30, 2020, with an expansion to include Medicare Advantage members for critical behavioral healthcare in an additional 13 states. This expands total enrolled members beyond 12,000 and up 40% sequentially from Q1 2020. While numerous companies are experiencing YoY sales decline, Ontrak is reporting triple digit growth rates which underscores a perfect storm of factors that make it luminate even brighter against the dark backdrop of the universe of stocks. How do you justify a $1 billion market cap for a company looking at $90 million in full-year 2020 revenues?  The current market appetite for telemedicine stocks is voracious with price-to-sales (PS) ratios ranging from 20 to 23X. Here’s a look at the trajectories for the shares both upside and downside from here.

OnTrak (NASDAQ: OTRK) Narrative, Stock Hitting on All Cylinders Towards These Levels

OTRK Price Trajectories

Using the rifle charts on the monthly and weekly time frames provides a broader view of the landscape for OTRK stock. The monthly rifle chart formed a bullish pup breakout with a stochastic rising towards the 80-band. The pup breakout went parabolic blasting through the monthly upper Bollinger Bands (BBs) at $48.28 and The 5-period moving average (MA) is at the $34.40 fib. The weekly rifle chart triggered a  market structure low (MSL) buy trigger above $21.00. The weekly pup and stochastic mini pup squeezed through the 90-band surpassing the $50.75 upper BBs with 5-period MA at $38.03. OTRK shares are driven by the perfect confluence of factors triggered by the pandemic and currently trading around P/S of 23X. The super thin 17 million share float can keep share elevated for extended periods of time which should propel prices towards upside trajectories at $68.07 fib, $75.84 fib and $81.69 fib. In the absence of gravity (above the upper BBs), inertia takes over.

In parabolic situations, the upper BBs are key bumpers that bulls must protect. If shares fall under the upper BBs at $50.75 and $48.28, then prices can quickly fall as gravity kicks in back to the 5-period MAs at $38.03 (weekly) and $34.25 (monthly). Potential opportunistic pullback levels are at the $44.29 fib, $38.03 weekly 5-period MA and $34.25 monthly 5-period MA. This is a thinly traded stock that gets thinner as price appreciates. Only nimble traders and active investors should even consider playing. It pays to monitor TDOC price action as a lead indicator.


7 Tech Stocks That Are Heating Up as Anti-Trust Talk Cools Down

For the better part of the last year, Congress has had “big tech” in its crosshairs. But the reasons why largely depend on what side of the aisle a particular individual was on.

On the one hand, there are politicians who are concerned about the role that technology companies play in restricting the free flow of information. On the other hand, there are politicians that are concerned about these companies' stranglehold on competitors and innovation.

But big tech scored an important, albeit not final, victory in late June. At that time, a U.S. judge dismissed two separate complaints against Facebook (NASDAQ:FB). The question in front of the judge was whether Facebook held a monopoly on social media. Due to a surge in the company’s stock price after the ruling, Facebook became a member of the exclusive $1 trillion market cap club. While big tech companies will remain under the Congressional microscope, there’s no denying that investors are looking at the ruling as a signal to rotate back into tech stocks. And that’s the focus of this presentation. What tech stocks should you be buying as anti-trust pressure eases?

It would be easy to start and end the list with the FAANG stocks. After all, the motto “Keep it Simple Stupid” comes to mind. There are simply those companies that offer products that are changing our lives now and will continue to do so in the future. And furthermore, customers will continue to pay for their products.

And I do have a couple of these stocks on my list. But the bulk of the stocks on this list are less expensive alternatives to at least one of the FAANG stocks. It doesn’t mean they’re superior companies, but a rising tide tends to lift all boats. And that means these companies have a large upside and you can purchase the stocks for a lot less.

View the "7 Tech Stocks That Are Heating Up as Anti-Trust Talk Cools Down".

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
UnitedHealth Group (UNH)3.3$428.07+1.8%1.35%28.27Buy$460.75
Livongo Health (LVGO)1.7$139.77flatN/A-349.42Hold$149.67
Compare These Stocks  Add These Stocks to My Watchlist 


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.